Squarepoint’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-24,572
| Closed | -$832K | – | 4834 |
|
|
2025
Q4 | $832K | Buy |
+24,572
| New | +$763K | ﹤0.01% | 2764 |
|
|
2024
Q3 | – | Sell |
-13,499
| Closed | -$329K | – | 4591 |
|
|
2024
Q2 | $329K | Buy |
+13,499
| New | +$624K | ﹤0.01% | 3369 |
|
|
2022
Q1 | – | Sell |
-1,417
| Closed | -$416K | – | 3391 |
|
|
2021
Q4 | $416K | Sell |
1,417
-1,753
| -55% | -$469K | ﹤0.01% | 2267 |
|
|
2021
Q3 | $787K | Buy |
3,170
+1,657
| +110% | +$438K | ﹤0.01% | 1704 |
|
|
2021
Q2 | $385K | Sell |
1,513
-58
| -4% | -$10.8K | ﹤0.01% | 2337 |
|
|
2021
Q1 | $279K | Sell |
1,571
-1,936
| -55% | -$319K | ﹤0.01% | 2462 |
|
|
2020
Q4 | $554K | Buy |
+3,507
| New | +$763K | ﹤0.01% | 1741 |
|
|
2020
Q3 | – | Sell |
-26,502
| Closed | -$12.6M | – | 2780 |
|
|
2020
Q2 | $12.6M | Buy |
26,502
+24,174
| +1,038% | +$3.74M | 0.2% | 123 |
|
|
2020
Q1 | $396K | Buy |
+2,328
| New | +$530K | 0.01% | 1160 |
|
Squarepoint's RAPT Position: Q1 2026 in Review
Squarepoint sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 24,572 shares — an estimated $832K sold.
Squarepoint first reported a position in RAPT in Q1 2020 and held it in 9 quarters. The position peaked at $12.6M in Q2 2020. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.
- Squarepoint reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
- Squarepoint sold 24,572 RAPT Therapeutics shares in Q1 2026, an estimated $832K.
- Squarepoint first reported a position in RAPT Therapeutics in Q1 2020 and held it in 9 quarters.
- Squarepoint's RAPT Therapeutics position peaked at $12.6M in Q2 2020.
- 0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.